Krilogy Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.6M Sell
15,066
-7,033
-32% -$1.14M 0.07% 214
2026
Q2
$3.02M Buy
22,099
+2,542
+13% +$312K 0.09% 183
2026
Q1
$2.49M Buy
19,557
+8,801
+82% +$1.23M 0.08% 196
2025
Q4
$1.76M Sell
10,756
-2,906
-21% -$455K 0.06% 230
2025
Q3
$1.99M Sell
13,662
-6,539
-32% -$794K 0.07% 196
2025
Q2
$2.51M Buy
+20,201
New +$2.57M 0.14% 119

Other funds holding RGEN

Krilogy Financial's RGEN Position: Q3 2026 in Review

Krilogy Financial reduced its Repligen (RGEN) stake by 32% in Q3 2026, selling an estimated $1.14M and leaving 15,066 shares worth $2.6M. The position accounts for 0.07% of the portfolio, ranked #214.

Krilogy Financial first reported a position in RGEN in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.02M in Q2 2026. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Krilogy Financial held 15,066 shares of Repligen worth $2.6M as of Q3 2026.
  • Krilogy Financial sold 7,033 Repligen shares in Q3 2026, an estimated $1.14M.
  • Repligen made up 0.07% of Krilogy Financial's portfolio in Q3 2026, its #214 holding.
  • Krilogy Financial first reported a position in Repligen in Q2 2025 and has held it in 6 quarters since.
  • Krilogy Financial's Repligen position peaked at $3.02M in Q2 2026.
  • 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.